Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.4900
-0.0100 (-2.00%)
Aug 27, 2025, 12:20 PM EDT
-2.00%
Market Cap37.52M
Revenue (ttm)10.88K
Net Income (ttm)-4.01M
Shares Out76.57M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume7,675
Open0.4900
Previous Close0.5000
Day's Range0.4900 - 0.4900
52-Week Range0.2800 - 1.2500
Beta0.48
RSI35.60
Earnings DateAug 29, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.